4'-ethynyl-2'-deoxyadenosine derivatives and their use in hiv therapy
WO2021024114A1
4'-ethynyl-2'-deoxyadenosine derivatives and their use in hiv therapy
WO2021004912A1
Streptomyces clavuligerus
WO2020044257A1
Compounds useful in hiv therapy
CA3108635A1
Compounds useful in hiv therapy
GB201909698D0
Streptomyces clavuligerus
WO2019186342A1
Ionic liquid salts of 4-(((3ar,5ar,5br,7ar,9s,11ar,11br,13as)-3a-((r)-2-((4-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-1-hydroxyethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2h-cyclopenta[a]chrysen-9-yl)oxy)-2,2-dimethyl-4-oxobutanoic acid
WO2019171285A1
Compounds useful in hiv therapy
WO2019150300A1
Crystalline forms of 4-(((3ar,5ar,5br,7ar,9s,11ar,11br,13as)-3a-((r)-2-((4-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-1-hydroxyethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2h-cyclopenta[a]chrysen-9-yl)oxy)-2,2-dimethyl-4-oxobutanoic acid
GB201814167D0
Compounds
GB201811849D0
Chemical compound
WO2018185701A1
Trpv4 antagonists as antitussive agents
EP3589618A1
Pyrazole derivatives as bromodomain inhibitors
TW201829462A
Binding proteins
WO2018055527A1
Trpv4 antagonists
KR20190049865A
TRPV4 antagonist
TW201825458A
TRPV 4 antagonists
WO2018042331A1
Combinations and uses and treatments thereof
WO2018042332A1
Combinations and uses and treatments thereof
TW201817714A
Compounds that inhibit 3C and 3CL proteases and methods of use thereof
